EDGAR Filing Documents for 0000898432-06-000462

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

SEC Accession No. 0000898432-06-000462

Filing Date

2006-05-11

Accepted

2006-05-11 16:53:17

Documents

Group Members

BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq	Description	Document	Type	Size
1		migenix13da.htm	SC 13D/A	113811
2	EXHIBIT 1 AMENDED AND RESTATED AGREEMENT	migenix13da-ex1.htm	EX-99	12270
3	(EXHIBIT 2)	exhibit2.htm	EX-99	184214
	Complete submission text file	0000898432-06-000462.txt		312686

Mailing Address BC RESEARCH COMPLEX 3650 WESBROOK MALL VANCOUVER A1 V6S2L2

Business Address 1750 609 GRANVILLE ST VANCOUVER B C CANADA A1 00000 (604) 221-9666

MIGENIX Inc. (Subject) CIK: 0000915458 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0430
Type: SC 13D/A | Act: 34 | File No.: 005-78624 | Film No.: 06830816
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606

Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice